Thursday, 21 October 2021

 

 

LATEST NEWS T20 World Cup : Wanindu Hasaranga, Pethum Nissanka and bowlers secure dominant win for Sri Lanka Win against Itsuki Hirata can put an Indian woman on global MMA stage : Ritu Phogat 'Dybbuk: The Curse is Real' is not for the weak-hearted Amid border dispute with China, Army makes integrated defence locations along LAC Security agencies probing larger conspiracy in Kashmir killings including Pak role Charanjit Singh Channi Greets People On Pragat Diwas Of Bhagwan Valmiki Ji & Exhorts To Follow Adi-Kavi’s Teachings Charanjit Singh Channi Announces Memorial Gate And Stadium In Memory Of Martyr Mandeep Singh Punjab Police Foil A Major Weapon & Drugs Smuggling Bid Via Indo-Pak Border Innovate, research, reform and perform: Shri Bandaru Dattatraya at international tech summit Kerala floods: 42 dead, six still missing T20 World Cup : Wiese's fifty powers Namibia to 6-wicket win over Netherlands 46 dead, 11 reported missing in U'khand flash floods, landslides Sukriti Kakkar, Prakriti Kakkar light up iconic Times Square billboard No bail for Aryan Khan, 2 others, to move Bombay HC on Thursday These tournaments are a real source of motivation : Bala Devi on AFC Women's Asian Cup 2022 Pakistan, India need a cricketing bond: PCB Chairman Ramiz Raja Madhuri Dixit shares quirky dance reel that many women will relate with Samantha Ruth Prabhu files defamation cases against YouTube channels Leaked 'Salaar' video triggers negative reaction among fans T20 World Cup : Hardik Pandya should be ready to bowl when India play first game, says Rohit Sharma Abhishek Bachchan, Amit Sadh to face off in new season of 'Breathe'

 

Pfizer's Covid vax not allowed yet for emergency use in India

Web Admin

Web Admin

5 Dariya News

New Delhi , 05 Feb 2021

India's drug regulatory authority has withheld approval of Pfizer's Covid vaccine after the Subject Expert Committee (SEC) said that it does not recommend granting permission for its emergency use authorisation (EUA) in the country "at this stage".The Central Drugs Standard Control Organisation's (CDSCO) expert committee has noted number of serious adverse events (SAE) observed post-marketing of the Pfizer vaccine in other countries as a prime reason behind its non-recommendation for EUA here, minutes of the meeting accessed by IANS said."The committee noted that incidents of palsy, anaphylaxis and other SAEs have been reported during post-marketing and the causality of the events with the vaccine is being investigated," the committee observed, as per the document.Besides, the SEC noted that the firm has not proposed any plan to generate safety and immunogenicity data "in Indian population"."After detailed deliberation, the committee has not recommended grant of permission for emergency use in the country at this stage," the directions from experts' committee in the document said.

The US-based pharmaceutical giant was the first drugmaker to apply for the EUA of its Covid vaccine in the country on December 5. The Pune-based Serum Institute of India followed it on December 6 for EUA of Covishield while Bharat Biotech sought EUA for Covaxin on December 7.Both Covishield and Covaxin were permitted for EUA on January 3 by the Drug Controller General of India. Their administration is underway in the country's Covid immunisation programme.Meanwhile, Pfizer has issued a statement, saying that it has withdrawn its application for now and would re-apply with the additional data in hand sought by the SEC."Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time," it said in the statement."Pfizer will continue to engage with the authority and re-submit its approval request with additional information as it becomes available in the near future," the company added.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , Covaxin , Covishield , Covid-19 Vaccine , Covid-19 Vaccine in India , COVID-19 Vaccination , COVID Vaccination , Pfizer , Subject Expert Committee , Central Drugs Standard Control Organisation's , CDSCO

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD